Keral (Dexketoprofen)

Dexketoprofen works by reversibly blocking both COX‑1 and COX‑2 enzymes, which are responsible for producing prostaglandins. Lower prostaglandin levels diminish inflammation, pain signalling and fever, resulting in an overall analgesic and anti‑inflammatory effect.

The appropriate dose of Keral is determined by the prescribing healthcare professional based on the patient’s condition, age, weight and overall health. Dosage regimens are individualized and should follow the prescriber’s instructions.

Safety data for dexketoprofen in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To order Keral, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Both Keral (dexketoprofen) and ibuprofen belong to the NSAID class and share similar mechanisms of COX inhibition. Dexketoprofen is the active enantiomer of ketoprofen and often provides faster pain relief at lower doses, whereas ibuprofen is widely used with a longer history of generic availability.

Keral should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Keral is taken orally, usually with a glass of water. It can be taken with or without food, but taking it with food may reduce occasional stomach irritation. Patients should follow the dosing schedule prescribed by their clinician.

Serious risks include gastrointestinal bleeding or ulceration, acute kidney injury, and severe allergic reactions such as anaphylaxis or skin disorders like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they notice signs of bleeding, sudden kidney problems or severe rash.

Keral should be avoided in individuals with known hypersensitivity to dexketoprofen or other NSAIDs, active gastrointestinal ulcer disease, severe heart failure, uncontrolled hypertension, or significant renal impairment. It is also contraindicated in patients receiving certain anticoagulants or other NSAIDs without medical supervision.